Skip to main content

3 Result(s)

within M. Merger Remove this filter

and

  1. Article

    Open Access

    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

    BI 2536, a novel Polo-like kinase 1 inhibitor, was assessed in patients with unresectable advanced exocrine adenocarcinoma of the pancreas.

    K Mross, C Dittrich, W E Aulitzky, D Strumberg, J Schutte… in British Journal of Cancer (2012)

    Download PDF (426 KB) View Article

  2. No Access

    Article

    Retroperitoneal gas gangrene after colonoscopic polypectomy without bowel perforation in an otherwise healthy individual: report of a case

    Abdominal gas gangrene caused by clostridia species is rare and usually associated with organ perforation, immune suppression, or advanced malignoma.

    L. Boenicke, M. Maier, M. Merger, M. Bauer… in Langenbeck's Archives of Surgery (2006)

  3. No Access

    Article

    Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine

    The effects of agonists and antagonists of 5-hydroxytryptamine (5-HT) receptors on the release of endogenous 5-HT from enterochromaffin cells were studied in the vascularly perfused isolated guinea-pig small i...

    A. Gebauer, M. Merger, H. Kilbinger in Naunyn-Schmiedeberg's Archives of Pharmacology (1993)